female genital neoplasms

Summary

Summary: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).

Top Publications

  1. Narayanan P, Iyngkaran T, Sohaib S, Reznek R, Rockall A. Pearls and pitfalls of MR lymphography in gynecologic malignancy. Radiographics. 2009;29:1057-69; discussion 1069-71 pubmed publisher
    ..However, as with any technique, there are pitfalls that the radiologist must be aware of to avoid interpretative errors...
  2. Nakai G, Matsuki M, Inada Y, Tatsugami F, Tanikake M, Narabayashi I, et al. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr. 2008;32:764-8 pubmed publisher
    ..In this study, the potential in detecting and evaluating pelvic lymph node metastases on body diffusion-weighted (DW) images was evaluated in patients with gynecologic malignancies...
  3. Narayanan P, Iyngkaran T, Sohaib S, Reznek R, Rockall A. Magnetic resonance lymphography: a novel technique for lymph node assessment in gynecologic malignancies. Cancer Biomark. 2009;5:81-8 pubmed publisher
    ..Magnetic resonance lymphography (MRL) using iron oxide nanoparticles is a new technique for lymph node assessment which has shown much promise. This article discusses the applications of MRL in the setting of gynecological malignancy...
  4. Laky B, Janda M, Bauer J, Vavra C, Cleghorn G, Obermair A. Malnutrition among gynaecological cancer patients. Eur J Clin Nutr. 2007;61:642-6 pubmed
    ..To assess the nutritional status of patients with gynaecological cancer...
  5. Penson R, Wenzel L, Vergote I, Cella D. Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S247-57 pubmed
    ..The QOL issues facing gynecologic cancer patients, the use of validated QOL instruments, recent advances in the evaluation of interventions, and changes in concepts related to QOL are reviewed...
  6. Yen T, Lai C. Positron emission tomography in gynecologic cancer. Semin Nucl Med. 2006;36:93-104 pubmed
    ..Evaluating PET by clinical benefit is specific to the individual tumor and an attractive new endpoint...
  7. Loar P, Reynolds R. Sentinel lymph node mapping in gynecologic malignancies. Int J Gynaecol Obstet. 2007;99:69-74 pubmed
    ..Sentinel node mapping is currently being investigated for treatment of gynecologic cancers. Recent studies show promise for incorporating the sentinel node mapping technique for treatment of several gynecologic malignancies...
  8. Laky B, Janda M, Cleghorn G, Obermair A. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr. 2008;87:1678-85 pubmed
    ..Few studies have assessed global nutritional assessment tools and body-composition measurements in gynecologic cancer patients...
  9. Molassiotis A, Browall M, Milovics L, Panteli V, Patiraki E, Fernandez Ortega P. Complementary and alternative medicine use in patients with gynecological cancers in Europe. Int J Gynecol Cancer. 2006;16 Suppl 1:219-24 pubmed
    ..It is important to discuss CAM use with gynecological cancer patients, as they frequently use it and such use may have implications for clinical practice...

More Information

Publications108 found, 100 shown here

  1. Fasching P, Thiel F, Nicolaisen Murmann K, Rauh C, Engel J, Lux M, et al. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer. 2007;15:1277-1284 pubmed publisher
    ..Our interest was to evaluate the association between CAM use and the patients' quality of life/life satisfaction (QoL/LS)...
  2. Kidger J, Murdoch J, Donovan J, Blazeby J. Clinical decision-making in a multidisciplinary gynaecological cancer team: a qualitative study. BJOG. 2009;116:511-7 pubmed publisher
    ..Improvements are needed to ensure patient-centred information is included for all women and that clear decisions are reached and recorded in all cases. ..
  3. Matsuo K, Eno M, Im D, Rosenshein N. Pregnancy and genital sarcoma: a systematic review of the literature. Am J Perinatol. 2009;26:507-18 pubmed publisher
    ..Genital sarcomas in pregnancy are rare. There is a delay in diagnosis due to low index of suspicion. A majority had live births, and the 5-year survival is similar to that of advanced-stage sarcoma in nonpregnant women. ..
  4. Grammatikakis I, Botsis D, Grigoriou O, Dalamanga A, Creatsas G. Fibronectin plasma levels in gynecological cancers. J BUON. 2010;15:122-6 pubmed
    ..Whether or not FBN could reliably be a marker for gynecological cancers should be confirmed in studies with larger number of patients. ..
  5. Srivastava R, Thakar R, Sultan A. Female sexual dysfunction in obstetrics and gynecology. Obstet Gynecol Surv. 2008;63:527-37 pubmed publisher
    ..While there are multiple treatment options available, integrated therapy which deals with both the psyche and the soma yield best results. Sexual counseling plays a vital role when therapy becomes necessary. ..
  6. Baldwin A, Usher K. Going the distance--experiences of women with gynaecological cancer residing in rural remote north Queensland. Int J Nurs Pract. 2008;14:322-8 pubmed publisher
    ..The results show the inherent difficulties in accessing support in rural areas and the difficulties associated with travelling considerable distances to undergo treatment. ..
  7. Espejel F, Roa J. [Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology]. Med Clin (Barc). 2008;131:312-7 pubmed
  8. Katz A. Interventions for sexuality after pelvic radiation therapy and gynecological cancer. Cancer J. 2009;15:45-7 pubmed publisher
    ..This psychological impact combined with the physical sensations of the disease itself and treatment side effects may lower both interest in sex and frequency of sexual activity. ..
  9. Deodato F, Macchia G, Grimaldi L, Ferrandina G, Lorusso D, Salutari V, et al. Stereotactic radiotherapy in recurrent gynecological cancer: a case series. Oncol Rep. 2009;22:415-9 pubmed
    ..Further studies of extracranial stereotactic radiotherapy and novel radiotherapy techniques are warranted in the challenging setting of recurrent gynecological tumors. ..
  10. Mohammad A, Makaju R. Retrospective histopathological analysis of various neoplasms of the female reproductive system (FRS) seen at the Kathmandu University Teaching Hospital, (KUTH) Dhulikhel, Nepal. Kathmandu Univ Med J (KUMJ). 2006;4:48-53 pubmed
    ..There were relatively a large number of cases of advanced stage of cancer of uterine cervix. All breast cancers seen were also in advanced stage. Endometrial carcinoma was conspicuously absent in our this small series of cases. ..
  11. Saynak M, Kucucuk S, Aslay I. Abdominal pillow for the sparing of small bowel in four-field conventional pelvic radiotherapy. Eur J Gynaecol Oncol. 2008;29:643-8 pubmed
    ..This study demonstrates that the small intestines can be displaced out of the radiation field by an abdominal pillow in the prone position. Also, this noninvasive technique provides for reduction of acute gastrointestinal morbidity. ..
  12. Narayanan P, Nobbenhuis M, Reynolds K, Sahdev A, Reznek R, Rockall A. Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics. 2009;29:1073-83 pubmed publisher
  13. Carpenter K, Fowler J, Maxwell G, Andersen B. Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med. 2010;39:79-90 pubmed publisher
  14. Jahan N, Narayanan P, Rockall A. Magnetic resonance lymphography in gynaecological malignancies. Cancer Imaging. 2010;10:85-96 pubmed publisher
  15. Goff B. Quality measures in gynecologic cancers: what and when?. Gynecol Oncol. 2008;110:3-4 pubmed publisher
  16. Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia. 2008;63:1332-8 pubmed publisher
    ..The clinical risks of cell salvage in these circumstances should be reviewed in the light of the risks of allogeneic blood transfusion. ..
  17. Forner D, Meyer A, Lampe B. Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergoing pelvic exenteration. Eur J Obstet Gynecol Reprod Biol. 2010;148:182-5 pubmed publisher
    ..Preoperative MRI cannot predict the surgical outcome with sufficient accuracy, hence on its own is inappropriate for prediction of complete tumour resection and final histological margin status in patients undergoing PE. ..
  18. Ismiil N, Ghorab Z, Nofech Mozes S, Plotkin A, Covens A, Osborne R, et al. Intraoperative consultation in gynecologic pathology: a 6-year audit at a tertiary care medical center. Int J Gynecol Cancer. 2009;19:152-7 pubmed publisher
    ..quot; ..
  19. An Y, Kim D. 18F-fluorodeoxyglucose PET/CT in a patient with esophageal and genital leiomyomatosis. Korean J Radiol. 2009;10:632-4 pubmed publisher
    ..In our case, (18)F-fluorodeoxyglucose positron emission tomography/computed tomography was used to distinguish esophageal and genital leiomyomatosis from malignant masses. ..
  20. Temkin S, Yamada S, Fleming G. A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and/or recurrent gynecologic malignancies. Gynecol Oncol. 2010;117:473-6 pubmed publisher
    ..The regimen may be safe in women who have not previously received radiation, but full doses of each agent could not be administered in combination. ..
  21. Fenoglietto P, Ailleres N, Lemanski C, Llacer C, Dubois J, Azria D. [RapidArc technology: first year of experience at the Montpellier comprehensive cancer centre]. Bull Cancer. 2010;97:769-78 pubmed publisher
    ..The technique, the results of the dosimetry plans, and quality control of the 142 first patients treated since November 2008 are presented in this review. ..
  22. Zalewski K, Doniec J, Baranowski W, Bidzinski M. [Revised FIGO staging systems for gynecologic malignancies--2009 update]. Ginekol Pol. 2010;81:778-82 pubmed
    ..Pelvic and para-aortic node involvement have been separated. The committee has also established a sarcoma staging system based on the criteria used in other soft tissue sarcomas. ..
  23. Sugiyama V, Chan J, Kapp D. Management of melanomas of the female genital tract. Curr Opin Oncol. 2008;20:565-9 pubmed publisher
    ..The results of treatment for female genital tract melanomas remain poor. Although surgery remains the initial treatment of choice for localized disease, adjuvant local-regional, and systemic therapies are needed. ..
  24. Leal Rojas P, Anabalón Rodríguez L, García Muñoz P, Tapia Escalona O, Guzmán González P, Araya Orostica J, et al. [Promoter hypermethylation gene patterns in gynecological tumors]. Med Clin (Barc). 2009;132:371-6 pubmed publisher
    ..In addition to complementary studies (ie, loss of expression and/or function), this represents a clinical tool for the proper management of the disease. ..
  25. López A, McCaffrey R, Quinn Griffin M, Fitzpatrick J. Spiritual well-being and practices among women with gynecologic cancer. Oncol Nurs Forum. 2009;36:300-5 pubmed publisher
    ..Nurses can assume a role in encouraging spiritual practices and enhancing spiritual well-being in women with cancer. ..
  26. Ulmer H, Borena W, Rapp K, Klenk J, Strasak A, Diem G, et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer. 2009;101:1202-6 pubmed publisher
    ..No other associations were found. Our findings support the hypothesis that STG concentrations are involved in the pathogenesis of lung, rectal, thyroid, prostate, and gynaecological cancers. ..
  27. Fader A, Rose P. Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel. Int J Gynecol Cancer. 2009;19:1281-3 pubmed publisher
    ..Further studies are ongoing to determine the clinical activity of Abraxane in the treatment of these malignancies. ..
  28. Levin A, Carpenter K, Fowler J, Brothers B, Andersen B, Maxwell G. Sexual morbidity associated with poorer psychological adjustment among gynecological cancer survivors. Int J Gynecol Cancer. 2010;20:461-70 pubmed publisher
  29. Ferguson S, Malhotra T, Seshan V, Levine D, Sonoda Y, Chi D, et al. A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery. Gynecol Oncol. 2009;114:111-6 pubmed publisher
    ..Women requiring major open surgery for gynecologic cancer should be offered PCEA for postoperative pain management if there are no contraindications. ..
  30. Sahin K, Akdemir F, Tuzcu M, Sahin N, Onderci M, Ozercan R, et al. Genistein suppresses spontaneous oviduct tumorigenesis in quail. Nutr Cancer. 2009;61:799-806 pubmed publisher
    ..Clinical trials should be conducted to investigate the efficacy of genistein supplementation in the prevention and treatment of uterine leiomyoma in humans. ..
  31. Okadome M, Saito T, Miyahara D, Yamanaka T, Kuroiwa T, Kurihara Y. Postoperative pulmonary embolism including asymptomatic cases in gynecologic oncology. Int J Gynecol Cancer. 2010;20:655-63 pubmed publisher
    ..Increasing age, longer operation time, and obesity were risks. The use of a perioperative intermittent pneumatic compression device in multimodal conditions might thus prevent PE. ..
  32. Jillani K, Khero R, Maqsood S, Siddiqui M. Prevalence of malignant disorders in 50 cases of postmenopausal bleeding. J Pak Med Assoc. 2010;60:540-3 pubmed
    ..This study showed a high prevalence of malignant disorders (30%) with carcinoma of cervix and endometrium having an equal contribution. Multiparity was the most significant factor for carcinoma of endometrium. ..
  33. Press J, Kenyon J, Xue H, Miller M, De Luca A, Miller D, et al. Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy. Gynecol Oncol. 2008;110:256-64 pubmed publisher
  34. Mueller B, Chow E, Kamineni A, Daling J, Fraser A, Wiggins C, et al. Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med. 2009;163:879-86 pubmed publisher
    ..Increased occurrence of preterm delivery and low birth weight suggest that close monitoring is warranted. Increased diabetes and anemia among subgroups have not been reported, suggesting areas for study. ..
  35. Bellomi M, Viotti S, Preda L, D Andrea G, Bonello L, Petralia G. Perfusion CT in solid body-tumours. Part II: Clinical applications and future development. Radiol Med. 2010;115:858-74 pubmed publisher
    ..Increased clinical application is desirable, especially in relation to a wider use of antiangiogenic drugs. Additional and ideally multicentre studies are necessary to define the role of this technique. ..
  36. Ohene Yeboah M, Bewtra C. Aggressive angiomyxoma in African women: a report of two cases. West Afr J Med. 2009;28:333-6 pubmed
    ..The clinical and histopathological features of the tumours described in this report are consistent with a diagnosis of aggressive angiomyxoma. To the best of our knowledge this is the first ever report of AAM in black African women. ..
  37. Krekac D, Brozkova K, Knoflickova D, Hrstka R, Muller P, Nenutil R, et al. MDM2SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk. Oncology. 2008;74:84-7 pubmed publisher
    ..Our data clearly show neither association between SNP309 and cancer risk, nor the responsibility of G allele for increased MDM2 or decreased of p53 protein levels in human primary breast tumors. ..
  38. Matulonis U, Krag K, Krasner C, Atkinson T, Horowitz N, Lee H, et al. Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors. Gynecol Oncol. 2009;112:394-9 pubmed publisher
    ..Patients not undergoing upfront debulking surgery because of either advanced cancer or poor surgical risk had excess morbidity/mortality. Prospective studies to identify risk factors for toxicity prediction are needed. ..
  39. Brabham J, Cardenes H. Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience. Am J Clin Oncol. 2009;32:417-22 pubmed publisher
    ..It represents a reasonable potential therapeutic option in the salvage setting in patients who meet these criteria, particularly in women who are not candidates for or are unwilling to undergo radical salvage surgery. ..
  40. Forman E, Anders C, Behera M. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril. 2010;94:1652-6 pubmed publisher
    ..Gynecologic oncologists may be more likely than others to consider modifying treatment to preserve fertility. According to oncologists, patients may be willing to sacrifice more in survival than they would. ..
  41. Houreih M, Lin A, Eyden B, Menasce L, Harrison J, Jones D, et al. Alveolar rhabdomyosarcoma with neuroendocrine/neuronal differentiation: report of 3 cases. Int J Surg Pathol. 2009;17:135-41 pubmed publisher
    ..PAX:FKHR fusion transcript was identified in case 2, case 3 had a variant PAX3 transcript, and case 1 was negative. The data presented expands the known differentiation of alveolar rhabdomyosarcoma...
  42. Lehmann K. [Malignant neoplasms of the female pelvis]. Radiologe. 2009;49:753-64; quiz 765-6 pubmed publisher
    ..In patients with incidental findings of ovarian masses, CT and MRI can detect evidence of malignancy, although an exact differential diagnosis is not usually possible in this very heterogeneous group of ovarian tumors. ..
  43. Beesley V, Janda M, Eakin E, Auster J, Chambers S, Aitken J, et al. Gynecological cancer survivors and community support services: referral, awareness, utilization and satisfaction. Psychooncology. 2010;19:54-61 pubmed publisher
    ..Organizations should also consider strategies to keep services high on clinicians' radars. ..
  44. Blair A, Casas C. Gynecologic cancers. Prim Care. 2009;36:115-30, ix pubmed publisher
    ..In this article, the epidemiology, screening guidelines, and a review of management are presented for vulvar, cervical, ovarian, and endometrial cancer. ..
  45. Fuste P, Santamaria X, Carreras R. [New therapeutic strategies for human papillomavirus related anogenital lesions in HIV patients: highly active antiretroviral therapy and HPV vaccines]. Med Clin (Barc). 2008;131:30-4 pubmed
    ..Second generation vaccines, still to be developed, might better adapt the specific needs of these patients. ..
  46. Manne S, Winkel G, Rubin S, Edelson M, Rosenblum N, Bergman C, et al. Mediators of a coping and communication-enhancing intervention and a supportive counseling intervention among women diagnosed with gynecological cancers. J Consult Clin Psychol. 2008;76:1034-45 pubmed publisher
    ..These findings provide support for hypothesized mediators for CCI. The authors were less able to identify mediators for SC. Future research might benefit from identifying SC mediators. ..
  47. Mulvany N, Mitchell G, Allen D. Adenocarcinoma cells in Pap smears. Pathology. 2009;41:411-8 pubmed
  48. Watson M, Saraiya M, Ahmed F, Cardinez C, Reichman M, Weir H, et al. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer. 2008;113:2841-54 pubmed publisher
  49. Gigerenzer G, Wegwarth O. [Medical risk assessment--using the example of cancer screening]. Z Evid Fortbild Qual Gesundhwes. 2008;102:513-9; discussion 606-8 pubmed
    ..Hence, informed consent is unlikely to take place in everyday practice. Truly informed decision making in medicine requires more evidence and transparency for patients as well as a better statistical training of physicians...
  50. Wei S, Said Al Naief N, Hameed O. Estrogen and progesterone receptor expression is not always specific for mammary and gynecologic carcinomas: a tissue microarray and pooled literature review study. Appl Immunohistochem Mol Morphol. 2009;17:393-402 pubmed publisher
  51. Amant F, Brepoels L, Halaska M, Gziri M, Calsteren K. Gynaecologic cancer complicating pregnancy: an overview. Best Pract Res Clin Obstet Gynaecol. 2010;24:61-79 pubmed publisher
    ..Firstly, we describe general diagnostic and cancer-treatment-related problems. In the second part, organ pathology including breast, cervical, ovarian, endometrial and vulvar cancer is discussed...
  52. Frazier L, Miller V, Horbelt D, Delmore J, Miller B, Paschal A. Comparison of focus groups on cancer and employment conducted face to face or by telephone. Qual Health Res. 2010;20:617-27 pubmed publisher
    ..Telephone focus groups provide useful data and can reduce logistical barriers to research participation. Visual anonymity might help some participants feel more comfortable discussing certain personal issues...
  53. Liu S, Ercolano E, Siefert M, McCorkle R. Patterns of symptoms in women after gynecologic surgery. Oncol Nurs Forum. 2010;37:E133-40 pubmed publisher
    ..To explore patterns of symptoms over time and the relationships between selected demographic and clinical characteristics...
  54. Arteaga Gómez A, Aranda Flores C, Márquez Acosta G, Colin Valenzuela A. [Adnexal tumor and pregnancy: diagnosis and treatment]. Ginecol Obstet Mex. 2010;78:160-7 pubmed
    ..The finding of adnexal masses during pregnancy is an exceptional event. Its reported incidence is less than 5% and most cases resolve spontaneously as the pregnancy progresses...
  55. Plante M. Vaginal radical trachelectomy: an update. Gynecol Oncol. 2008;111:S105-10 pubmed publisher
    ..In this article, we analyze the data on the vaginal radical trachelectomy published over the last 10 years in the context of what we have learned, what issues remain unclear, and what the future holds...
  56. Balci O, Gezginc K, Karatayli R, Acar A, Celik C, Colakoglu M. Management and outcomes of adnexal masses during pregnancy: a 6-year experience. J Obstet Gynaecol Res. 2008;34:524-8 pubmed
    ..To demonstrate adnexal masses detected during gestations in a 6-year period...
  57. Weidner K, Siedentopf F, Zimmermann K, Bittner A, Richter J, Joraschky P, et al. Which gynecological and obstetric patients want to attend psychosomatic services?. J Psychosom Obstet Gynaecol. 2008;29:280-9 pubmed publisher
    ..The aim of this study is to explore the wish of gynecological and obstetric inpatients to attend psychosomatic services. Predictors influencing this wish are evaluated...
  58. Walton L, Reeve J, Brown P, Farquhar C. Gynaecologic cancer patients' needs and experiences of supportive health services in New Zealand. Psychooncology. 2010;19:201-8 pubmed publisher
    ..The purpose of this qualitative study was to identify needs for supportive care in a sample of New Zealand women and to understand to what extent they feel their needs are being met by health services...
  59. Platou T, Skjeldestad F, Rannestad T. Socioeconomic conditions among long-term gynaecological cancer survivors--a population-based case-control study. Psychooncology. 2010;19:306-12 pubmed publisher
    ..The aim of this study was to investigate the socioeconomic conditions in long-term survivors of gynaecological cancer compared with a representative group of women from the general population...
  60. Lim J, Yi J. The effects of religiosity, spirituality, and social support on quality of life: a comparison between Korean American and Korean breast and gynecologic cancer survivors. Oncol Nurs Forum. 2009;36:699-708 pubmed publisher
  61. Werbrouck J, De Ruyck K, Beels L, Vral A, Van Eijkeren M, De Neve W, et al. Prediction of late normal tissue complications in RT treated gynaecological cancer patients: potential of the gamma-H2AX foci assay and association with chromosomal radiosensitivity. Oncol Rep. 2010;23:571-8 pubmed
    ..This applies as well to the assessment of the repair kinetics after an HDR dose as to the determination of the number of residual foci after a LDR dose...
  62. Shen Gunther J. ON-Q anesthetic pump in gynecologic oncology: feasibility study of a novel placement technique at an army hospital. Mil Med. 2008;173:918-23 pubmed
  63. Marinovskij E, Kazlauskaite R, Dueholm M, Lundorf E. [Magnetic resonance imaging of the female pelvis]. Ugeskr Laeger. 2008;170:3213-6 pubmed
    ..MR also plays an increasing role in minimal access surgery...
  64. Gallardo A, Prat J. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol. 2009;33:278-88 pubmed publisher
    ..These findings suggest that some of the tumors currently classified as adenofibromas, on the basis of their low mitotic count and lack of significant nuclear atypia, are, in fact, well-differentiated adenosarcomas...
  65. Gatcliffe T, Coleman R. Tumor board: more than treatment planning--a 1-year prospective survey. J Cancer Educ. 2008;23:235-7 pubmed publisher
    ..The aim of this study was to evaluate the impact of gynecologic oncology tumor boards (TBs) on patient care and graduate education...
  66. Jarvinen H, Renkonen Sinisalo L, Aktan Collan K, Peltomaki P, Aaltonen L, Mecklin J. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol. 2009;27:4793-7 pubmed publisher
    ..The long-term effectiveness of surveillance was evaluated in Lynch syndrome family members tested approximately 10 years ago...
  67. Estrade J, Lazard A, Gurriet B, Agostini A, Blanc B. [Laparoscopic ways of para-aortic lymphadenectomy]. Gynecol Obstet Fertil. 2010;38:135-41 pubmed publisher
    ..Laparoscopy is an interesting technical procedure in this situation: it allows both staging and curative surgery. Two laparoscopic ways are eligible: transperitoneal lymphadenectomy and retroperitoneal lymphadenectomy...
  68. Waldenstrom A, Alsadius D, Pettersson N, Johansson K, Holmberg E, Steineck G, et al. Variation in position and volume of organs at risk in the small pelvis. Acta Oncol. 2010;49:491-9 pubmed publisher
    ..In preparation for studies of dose volume of ionizing radiation and long-term side effects, we assessed both variation in position and volume of organs at risk in the small pelvis...
  69. Lai B, Tang C, Chung T. A prospective longitudinal study investigating neuroticism and mastery as predictors of quality of life among Chinese gynecologic cancer survivors. Qual Life Res. 2010;19:931-41 pubmed publisher
    ..The aim of the study was to examine the role of neuroticism and mastery in predicting the quality of life (QOL) among Chinese gynecologic cancer survivors...
  70. Dirier A, Adli M, Andic F, Cifci S, Ors Y, Kuzhan A. Reduction of irradiated small bowel volume with Trendelenburg position in gynecologic pelvic radiotherapy. J Med Imaging Radiat Oncol. 2010;54:142-5 pubmed publisher
    ..Clinical benefit of this position should be evaluated in further clinical studies...
  71. Goonatillake S, Khong R, Hoskin P. Chemoradiation in gynaecological cancer. Clin Oncol (R Coll Radiol). 2009;21:566-72 pubmed publisher
    ..It is associated with increased toxicity and as with cervical cancer an emphasis on high-quality, high-dose, carefully planned megavoltage radiotherapy alone may make far greater gains in this population...
  72. Houghton O, McCluggage W. The expression and diagnostic utility of p63 in the female genital tract. Adv Anat Pathol. 2009;16:316-21 pubmed publisher
    ..p63 is also positive in cervical transitional metaplasia, Walthard rests, vulval Paget disease secondary to an underlying urothelial malignancy, tubulosquamous polyp of the vagina, and ectopic prostatic tissue in the cervix...
  73. Ayhan A, Basaran A, Güler T. Effects of oxidized regenerated methylcellulose on lymphocyst formation and peritoneum in gynecologic cancer patients. Int J Gynecol Cancer. 2010;20:23-7 pubmed publisher
    ..The role of oxidized regenerated methylcellulose (ORC) in the lymphocyst formation after systematic lymphadenectomy...
  74. Ratner E, Foran K, Schwartz P, Minkin M. Sexuality and intimacy after gynecological cancer. Maturitas. 2010;66:23-6 pubmed publisher
    ..The essential part of success is the providers appreciation of this serous problem and willingness and comfort in addressing it...
  75. McTiernan A, Irwin M, VonGruenigen V. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol. 2010;28:4074-80 pubmed publisher
    ..The effects of dietary weight loss and increase in physical activity on survival or recurrence in breast and gynecologic cancers are not yet established, and randomized controlled trials are needed for definitive data...
  76. Coleman R, Levine D. 44th Annual Meeting of the American Society of Clinical Oncology. Gynecol Oncol. 2008;110:123-4 pubmed
  77. Kaminski P, Bobrowska K, Pietrzak B, Bablok L, Wielgos M. Gynecological issues after organ transplantation. Neuro Endocrinol Lett. 2008;29:852-6 pubmed
    ..All transplant women must undergo regular gynecological screening for premalignant and malignant lesions of sex organs and breast...
  78. Volgger B, Petru E, Angleitner Boubenizek L, Weigert M, Reinthaller A, Lass H, et al. Erythropoetin beta twice weekly versus standard therapy in patients with gynaecological malignancies--a randomised Austrian AGO trial. Anticancer Res. 2008;28:3977-84 pubmed
    ..The influence of two regimens of erythropoetin beta on haemoglobin level, quality of life (QoL) and side-effects in patients with gynaecological malignancies was assessed...
  79. Hammer K, Mogensen O, Hall E. Hope as experienced in women newly diagnosed with gynaecological cancer. Eur J Oncol Nurs. 2009;13:274-9 pubmed publisher
    ..This article presents findings from a hermeneutic-phenomenological study with the aim to investigate the meaning of the lived experience of hope in women newly diagnosed with gynaecological cancer...
  80. Oehler M. Robot-assisted surgery in gynaecology. Aust N Z J Obstet Gynaecol. 2009;49:124-9 pubmed
    ..If evidence-based long-term outcome evaluations show the superiority of robotic surgery in comparison to conventional laparoscopic and open surgery, this technology will have a major impact on gynaecological surgery...
  81. Mendivil A, Holloway R, Boggess J. Emergence of robotic assisted surgery in gynecologic oncology: American perspective. Gynecol Oncol. 2009;114:S24-31 pubmed publisher
    ..To discuss the emergence of robotic surgery in gynecologic oncology and describe the growth of robotic surgery in a university medical center and a community based practice...
  82. Johnson N, Miles T, Cornes P. Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. BJOG. 2010;117:522-31 pubmed publisher
    ..UK guidelines recommend routine vaginal dilation during and after pelvic radiotherapy to prevent stenosis...
  83. Campos S, Berlin S, Parker L, Chen W, Bunnell C, Atkinson T, et al. Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer. Int J Clin Oncol. 2010;15:390-8 pubmed publisher
  84. Lipetskaia L, Silver D. Laparoscopic use of a hyaluronic acid carboxycellulose membrane slurry in gynecological oncology. JSLS. 2010;14:91-4 pubmed publisher
    ..We evaluated the use of a hyaluronic acid-carboxycellulose membrane (HAC) slurry in complex laparoscopies...
  85. Staiano J, Wong L, Butler J, Searle A, Barton D, Harris P. Flap reconstruction following gynaecological tumour resection for advanced and recurrent disease--a 12 year experience. J Plast Reconstr Aesthet Surg. 2009;62:346-51 pubmed publisher
    ..The complications associated with performing a major reconstructive procedure need to be balanced against the potential wound problems associated with leaving these advanced tumours untreated surgically...
  86. Königsrainer I, Aschoff P, Zieker D, Beckert S, Glatzle J, Pfannenberg C, et al. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis]. Zentralbl Chir. 2008;133:468-72 pubmed publisher
  87. Martin T, Jiang W. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta. 2009;1788:872-91 pubmed publisher
    ..This article will present data showing how modulation of expression of TJ molecules results in key changes in TJ barrier function leading to the successful metastasis of a number of different cancer types...
  88. Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, et al. Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol. 2009;27:812-26 pubmed publisher
    ..Sincerely, Richard L. Schilsky, MD President American Society of Clinical Oncology...
  89. Jaishuen A, Jimenez C, Sirisabya N, Li Y, Zheng H, Hu W, et al. Poor survival outcome with moderate and severe hypercalcemia in gynecologic malignancy patients. Int J Gynecol Cancer. 2009;19:178-85 pubmed publisher
    ..Determine the incidence of hypercalcemia in gynecologic malignancy patients and their survival outcome...
  90. Amant F, Van Calsteren K, Halaska M, Beijnen J, Lagae L, Hanssens M, et al. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer. 2009;19 Suppl 1:S1-12 pubmed publisher
    ..The gathering of both available literature and personal experience allowed only suggesting models for treatment of gynecologic cancer in pregnancy. ..
  91. Kolusari A, Ugurluer G, Kosem M, Kurdoglu M, Yildizhan R, Adali E. Leiomyosarcoma of the broad ligament: a case report and review of the literature. Eur J Gynaecol Oncol. 2009;30:332-4 pubmed
    ..The patient received pelvic radiotherapy and chemotherapy considering the high grade of malignancy. No evidence of metastasis has been noted after a follow-up of 12 months...
  92. Savvari P, Peitsidis P, Alevizaki M, Dimopoulos M, Antsaklis A, Papadimitriou C. Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review. Onkologie. 2009;32:517-23 pubmed publisher